GDTC
Price
$2.00
Change
+$0.01 (+0.50%)
Updated
Sep 2 closing price
Capitalization
23.53M
72 days until earnings call
NURPF
Price
$12.73
Change
+$1.76 (+16.04%)
Updated
Aug 28 closing price
Capitalization
1.62B
Interact to see
Advertisement

GDTC vs NURPF

Header iconGDTC vs NURPF Comparison
Open Charts GDTC vs NURPFBanner chart's image
CytoMed Therapeutics
Price$2.00
Change+$0.01 (+0.50%)
Volume$6.83K
Capitalization23.53M
Neuren Pharmaceuticals
Price$12.73
Change+$1.76 (+16.04%)
Volume$310
Capitalization1.62B
GDTC vs NURPF Comparison Chart in %
Loading...
GDTC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NURPF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
GDTC vs. NURPF commentary
Sep 03, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GDTC is a StrongBuy and NURPF is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 03, 2025
Stock price -- (GDTC: $2.01 vs. NURPF: $12.73)
Brand notoriety: GDTC and NURPF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: GDTC: 50% vs. NURPF: 47%
Market capitalization -- GDTC: $23.53M vs. NURPF: $1.62B
GDTC [@Biotechnology] is valued at $23.53M. NURPF’s [@Biotechnology] market capitalization is $1.62B. The market cap for tickers in the [@Biotechnology] industry ranges from $102.81B to $0. The average market capitalization across the [@Biotechnology] industry is $1.88B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GDTC’s FA Score shows that 0 FA rating(s) are green whileNURPF’s FA Score has 1 green FA rating(s).

  • GDTC’s FA Score: 0 green, 5 red.
  • NURPF’s FA Score: 1 green, 4 red.
According to our system of comparison, NURPF is a better buy in the long-term than GDTC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GDTC’s TA Score shows that 5 TA indicator(s) are bullish while NURPF’s TA Score has 3 bullish TA indicator(s).

  • GDTC’s TA Score: 5 bullish, 4 bearish.
  • NURPF’s TA Score: 3 bullish, 3 bearish.
According to our system of comparison, GDTC is a better buy in the short-term than NURPF.

Price Growth

GDTC (@Biotechnology) experienced а +1.78% price change this week, while NURPF (@Biotechnology) price change was +16.09% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -0.03%. For the same industry, the average monthly price growth was +15.69%, and the average quarterly price growth was +32.28%.

Reported Earning Dates

GDTC is expected to report earnings on Nov 14, 2025.

Industries' Descriptions

@Biotechnology (-0.03% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NURPF($1.62B) has a higher market cap than GDTC($23.5M). NURPF YTD gains are higher at: 68.230 vs. GDTC (-41.029).
GDTCNURPFGDTC / NURPF
Capitalization23.5M1.62B1%
EBITDAN/A108M-
Gain YTD-41.02968.230-60%
P/E RatioN/A17.05-
RevenueN/A141M-
Total CashN/AN/A-
Total DebtN/AN/A-
FUNDAMENTALS RATINGS
NURPF: Fundamental Ratings
NURPF
OUTLOOK RATING
1..100
39
VALUATION
overvalued / fair valued / undervalued
1..100
71
Overvalued
PROFIT vs RISK RATING
1..100
41
SMR RATING
1..100
17
PRICE GROWTH RATING
1..100
39
P/E GROWTH RATING
1..100
38
SEASONALITY SCORE
1..100
85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
GDTCNURPF
RSI
ODDS (%)
Bullish Trend 2 days ago
75%
Bearish Trend 2 days ago
54%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
65%
Momentum
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
64%
MACD
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
62%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
62%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 2 days ago
60%
Advances
ODDS (%)
Bullish Trend 2 days ago
85%
N/A
Declines
ODDS (%)
Bearish Trend 15 days ago
89%
N/A
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
60%
Aroon
ODDS (%)
Bearish Trend 2 days ago
87%
Bullish Trend 2 days ago
62%
View a ticker or compare two or three
Interact to see
Advertisement
GDTC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NURPF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SRG3.720.05
+1.36%
Seritage Growth Properties
AMWD64.19-0.38
-0.59%
American Woodmark Corp
TRP51.69-0.37
-0.71%
TC Energy Corp
BGC9.67-0.14
-1.43%
BGC Group
DRIO9.15-0.36
-3.79%
DarioHealth Corp

GDTC and

Correlation & Price change

A.I.dvisor tells us that GDTC and CYCN have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that GDTC and CYCN's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GDTC
1D Price
Change %
GDTC100%
+0.15%
CYCN - GDTC
30%
Poorly correlated
+1.62%
CVKD - GDTC
29%
Poorly correlated
-4.24%
QSI - GDTC
28%
Poorly correlated
-3.57%
ADIL - GDTC
27%
Poorly correlated
-0.87%
GRCE - GDTC
27%
Poorly correlated
-1.32%
More

NURPF and

Correlation & Price change

A.I.dvisor indicates that over the last year, NURPF has been loosely correlated with CGEN. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if NURPF jumps, then CGEN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NURPF
1D Price
Change %
NURPF100%
N/A
CGEN - NURPF
46%
Loosely correlated
+1.42%
ASPHF - NURPF
30%
Poorly correlated
N/A
SPHRF - NURPF
22%
Poorly correlated
N/A
KRRO - NURPF
21%
Poorly correlated
-3.79%
GDTC - NURPF
21%
Poorly correlated
+0.15%
More